(Q64117418)

17

object named as

Roch K Dabiré

0 references

Haoues Alout

object named as

Haoues Alout

2

0 references

Abdoulaye Diabaté

object named as

Abdoulaye Diabaté

14

0 references

author name string

Brian D Foy

1

0 references

Jonathan A Seaman

3

0 references

Sangeeta Rao

4

0 references

Martina Wade

6

0 references

Sunil Parikh

7

0 references

Dieudonné D Soma

8

0 references

André B Sagna

9

0 references

Florence Fournet

10

0 references

Hannah C Slater

11

0 references

Roland Bougma

12

0 references

François Drabo

13

0 references

A Gafar V Coulidiaty

15

0 references

Nöel Rouamba

The effect of malaria control on Plasmodium falciparum in Africa between 2000 and 2015

16

0 references

language of work or name

English

0 references

publication date

13 April 2019

0 references

published in

The Lancet

0 references

volume

393

0 references

issue

10180

0 references

page(s)

1517-1526

0 references

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2932321-3

7 January 2021

Artemisinin resistance: current status and scenarios for containment

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2932321-3

7 January 2021

Increased pyrethroid resistance in malaria vectors and decreased bed net effectiveness, Burkina Faso.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2932321-3

7 January 2021

Characterizing, controlling and eliminating residual malaria transmission

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2932321-3

7 January 2021

Successful malaria elimination strategies require interventions that target changing vector behaviours

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2932321-3

7 January 2021

Why Use of Interventions Targeting Outdoor Biting Mosquitoes will be Necessary to Achieve Malaria Elimination

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2932321-3

7 January 2021

Ivermectin to reduce malaria transmission: a research agenda for a promising new tool for elimination

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2932321-3

7 January 2021

Ivermectin mass drug administration to humans disrupts malaria parasite transmission in Senegalese villages

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2932321-3

7 January 2021

Evaluation of ivermectin mass drug administration for malaria transmission control across different West African environments

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2932321-3

7 January 2021

Ivermectin inhibits the sporogony of Plasmodium falciparum in Anopheles gambiae

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2932321-3

7 January 2021

Inhibition of Plasmodium Liver Infection by Ivermectin

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2932321-3

7 January 2021

Establishment of the Ivermectin Research for Malaria Elimination Network: updating the research agenda

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2932321-3

7 January 2021

Mass drug administration of ivermectin in south-eastern Senegal reduces the survivorship of wild-caught, blood fed malaria vectors

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2932321-3

7 January 2021

Force of infection is key to understanding the epidemiology of Plasmodium falciparum malaria in Papua New Guinean children

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2932321-3

7 January 2021

The potential impact of adding ivermectin to a mass treatment intervention to reduce malaria transmission: a modelling study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2932321-3

7 January 2021

Malaria incidence in children in South-West Burkina Faso: comparison of active and passive case detection methods

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2932321-3

7 January 2021

Endectocides for malaria control

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2932321-3

7 January 2021

Use of high-dose, twice-yearly albendazole and ivermectin to suppress Wuchereria bancrofti microfilarial levels

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2932321-3

7 January 2021

Integrating vector control across diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2932321-3

7 January 2021

An estimation of the entomological inoculation rate for Ifakara: a semi-urban area in a region of intense malaria transmission in Tanzania.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2932321-3

7 January 2021

Modelling heterogeneity in malaria transmission using large sparse spatio-temporal entomological data

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2932321-3

7 January 2021

Plasmodium falciparum signal recognition particle components and anti-parasitic effect of ivermectin in blocking nucleo-cytoplasmic shuttling of SRP.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2932321-3

7 January 2021

Drug screen targeted at Plasmodium liver stages identifies a potent multistage antimalarial drug

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2932321-3

7 January 2021

Prolonged clearance of microfilaraemia in patients with bancroftian filariasis after multiple high doses of ivermectin or diethylcarbamazine.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2932321-3

7 January 2021

Safety and mosquitocidal efficacy of high-dose ivermectin when co-administered with dihydroartemisinin-piperaquine in Kenyan adults with uncomplicated malaria (IVERMAL): a randomised, double-blind, placebo-controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2932321-3

7 January 2021

Viability of adult Onchocerca volvulus after six 2-weekly doses of ivermectin

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/30878222

12 December 2020

inferred from PubMed ID database lookup

[A study in the Ivory Coast (1985-1987) of the efficacy and tolerance of ivermectin (Mectizan) in human onchocerciasis. I. A comparative double-blind study of 220 patients with onchocerciasis treated with a single oral dose of 100, 150 or 200 mcg/kg

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/30878222

12 December 2020

inferred from PubMed ID database lookup

Lack of in vitro effect of ivermectin on Plasmodium falciparum.

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/30878222

12 December 2020